The Procter & Gamble Company (NYSE:PG) Stock Position Lowered by Delaney Dennis R

Delaney Dennis R lessened its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 0.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,190 shares of the company’s stock after selling 182 shares during the period. Procter & Gamble comprises approximately 3.9% of Delaney Dennis R’s investment portfolio, making the stock its 6th biggest holding. Delaney Dennis R’s holdings in Procter & Gamble were worth $7,288,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Alera Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 1.2% in the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the period. Hudson Value Partners LLC grew its stake in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after purchasing an additional 60 shares during the period. Fiduciary Alliance LLC increased its holdings in shares of Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after purchasing an additional 61 shares in the last quarter. LCM Capital Management Inc lifted its stake in shares of Procter & Gamble by 1.1% in the first quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock valued at $925,000 after purchasing an additional 63 shares during the period. Finally, Home Federal Bank of Tennessee increased its holdings in Procter & Gamble by 0.3% in the second quarter. Home Federal Bank of Tennessee now owns 23,318 shares of the company’s stock valued at $3,846,000 after buying an additional 63 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 1.1 %

Shares of NYSE:PG opened at $173.91 on Thursday. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The firm has a market cap of $410.45 billion, a price-to-earnings ratio of 28.42, a PEG ratio of 3.76 and a beta of 0.41. The stock’s 50-day moving average price is $169.94 and its two-hundred day moving average price is $165.55. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. During the same period in the prior year, the firm posted $1.37 EPS. The business’s revenue for the quarter was down .1% on a year-over-year basis. On average, research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Activity at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R. Alexandra Keith sold 3,373 shares of the business’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the completion of the sale, the chief executive officer now directly owns 21,513 shares of the company’s stock, valued at approximately $3,657,210. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 375,553 shares of company stock worth $63,829,141. 0.17% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

PG has been the topic of several research analyst reports. Citigroup boosted their price target on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Royal Bank of Canada boosted their target price on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. TD Cowen started coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target for the company. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 31st. Finally, BNP Paribas assumed coverage on shares of Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price for the company. Seven investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $175.79.

Read Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.